(Q45227450)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15654826%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

title

Taurine attenuates CD3/interleukin-2-induced T cell apoptosis in an in vitro model of activation-induced cell death (AICD) (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15654826%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15654826%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Claire Condron

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15654826%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

author name string

D J Bouchier-Hayes

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15654826%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

D M Toomey

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15654826%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

publication date

1 February 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15654826%20AND%20SRC:MED&resulttype=core&format=json

Clinical and Experimental Immunology

7 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15654826%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

volume

139

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15654826%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15654826%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

page(s)

279-286

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15654826%20AND%20SRC:MED&resulttype=core&format=json

Immunotherapy: past, present and future

7 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02694.X

Fas and the art of lymphocyte maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02694.X

CTLA-4-mediated inhibition in regulation of T cell responses: mechanisms and manipulation in tumor immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02694.X

Apoptosis by death factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02694.X

Activation-induced cell death: the controversial role of Fas and Fas ligand in immune privilege and tumour counterattack

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02694.X

Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02694.X

Taurine attenuates recombinant interleukin-2-activated, lymphocyte-mediated endothelial cell injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02694.X

Combined treatment with interleukin-18 and low-dose interleukin-2 induced regression of a murine sarcoma and memory response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02694.X

The in vivo and in vitro protective properties of taurine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02694.X

The involvement of caspases in the CD95(Fas/Apo-1)- but not swelling-induced cellular taurine release from Jurkat T-lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02694.X

Regulation of fas-ligand expression during activation-induced cell death in T lymphocytes via nuclear factor kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02694.X

NF-kappaB as a primary regulator of the stress response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02694.X

Suppression of bleomycin-induced nitric oxide production in mice by taurine and niacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02694.X

The NF-kappa B transcription factor and cancer: high expression of NF-kappa B- and I kappa B-related proteins in tumor cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02694.X

NF??B: A Pivotal Transcription Factor in Prostate Cancer Metastasis to Bone

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809279

Potentiation of the therapeutic index of interleukin-2 immunotherapy by combination with taurine in a syngeneic murine tumour model.

3 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809279

Inhibition of neutrophil apoptosis after elective surgery.

3 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809279

Phase I trial of simultaneous administration of interleukin 2 and interleukin 4 subcutaneously

3 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809279

Host defense--a role for the amino acid taurine?

3 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809279

Downregulation of Fas ligand by shedding

3 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809279

Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer

3 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809279

IL-2 induces Fas ligand/Fas (CD95L/CD95) cytotoxicity in CD8+ and CD4+ T lymphocyte clones

3 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809279

Induction of activation-driven death (apoptosis) in activated but not resting peripheral blood T cells

3 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809279

Activation interferes with the APO-1 pathway in mature human T cells.

3 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809279

Expression of the functional soluble form of human fas ligand in activated lymphocytes.

3 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809279

Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule

3 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809279

In vivo administration of purified human interleukin 2. II. Half life, immunologic effects, and expansion of peripheral lymphoid cells in vivo with recombinant IL 2.

3 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809279

Immunological properties of melanoma tumor-infiltrating lymphocytes before and after IL-2-based biotherapies

3 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809279

Epstein-Barr virus latent membrane protein transactivates the human immunodeficiency virus type 1 long terminal repeat through induction of NF-kappa B activity

3 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809279

Experience with the use of high-dose interleukin-2 in the treatment of 652 cancer patients

3 November 2018

1 reference

12 December 2020

Mechanisms involved in sodium arsenite-induced apoptosis of human neutrophils

1 reference

12 December 2020

The beneficial effect of taurine on the prevention of human endothelial cell death

1 reference

12 December 2020

Taurine attenuates nitric oxide- and reactive oxygen intermediate-dependent hepatocyte injury

1 reference

12 December 2020

Activated human T cells release bioactive Fas ligand and APO2 ligand in microvesicles

1 reference

12 December 2020

NF-kappa B-dependent Fas ligand expression

1 reference

12 December 2020

10.1111/J.1365-2249.2005.02694.X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15654826%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

0 references

1 reference